List of Nithiodote drug patents

Nithiodote is owned by Hope Pharms.

Nithiodote contains Sodium Nitrite; Sodium Thiosulfate.

Nithiodote has a total of 6 drug patents out of which 0 drug patents have expired.

Nithiodote was authorised for market use on 14 January, 2011.

Nithiodote is available in solution, solution;intravenous, intravenous dosage forms.

Nithiodote can be used as treatment of acute cyanide poisoning that is judged to be life threatening, sodium thiosulfate injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning, sodium nitrite injection is administered by intravenous injection; sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning, sodium thiosulfate injection is administered by intravenous injection.

The generics of Nithiodote are possible to be released after 24 December, 2031.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9585912 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(7 years from now)

US9345724 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(7 years from now)

US8496973 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Mar, 2031

(8 years from now)

US8568793 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Dec, 2031

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9687506 HOPE PHARMS Sodium nitrite-containing pharmaceutical compositions
Feb, 2030

(7 years from now)

US10479686 HOPE PHARMS Sodium thiosulfate-containing pharmaceutical compositions
Jul, 2030

(7 years from now)

Drugs and Companies using SODIUM NITRITE; SODIUM THIOSULFATE ingredient

Market Authorisation Date: 14 January, 2011

Treatment: Sodium nitrite injection is administered by intravenous injection; Sodium nitrite injection is indicated for sequential use with sodium thiosulfate for the treatment of acute cyanide poisoning; Sodium thiosulfate injection is administered by intravenous injection; Sodium thiosulfate injection is indicated for sequential use with sodium nitrite for the treatment of acute cyanide poisoning; Treatment of acute cyanide poisoning that is judged to be life threatening

Dosage: SOLUTION, SOLUTION;INTRAVENOUS, INTRAVENOUS

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in